A-Lices Scalp & Body Hygiene Shampoo

Main information

  • Trade name:
  • A-Lices Scalp & Body Hygiene Shampoo 1% w/v
  • Dosage:
  • 1% w/v
  • Pharmaceutical form:
  • Shampoo
  • Units in package:
  • Bottle, plastic, LDPE bottle, 30mL, 30 mL
  • Class:
  • General sale
  • Prescription type:
  • General sale
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Cheminova Agro A/S

Documents

Localization

  • Available in:
  • A-Lices Scalp & Body Hygiene Shampoo 1% w/v
    New Zealand
  • Language:
  • English

Other information

Status

  • Source:
  • Medsafe - Medicines Safety Authority - New Zealand
  • Authorization number:
  • 10952
  • Authorization date:
  • 10-09-2002
  • Last update:
  • 27-09-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

A-LICES Scalp & Body Hygiene Shampoo

Malathion 1%

What is in this leaflet

Please read this carefully before you use your medicine.

This leaflet provides a summary of the information available on your medicine.

If you have any concerns about this medicine, ask your doctor or pharmacist.

Keep this leaflet with the medicine. You may need to read it again.

WhatA-LICES Shampoo is used for and how it works:

A-LICES Shampoo is used for the treatment and eradication of head lice, body lice and their eggs.

Before you useA-LICES Shampoo

Do not use A-LICES Shampoo:

if you are allergic to Malathion or to any of the other ingredients;

to treat infants less than 6 months old, except on medical advice.

Before you start to use it

You must tell your doctor or pharmacistif you are pregnant or breast-feeding.

HowA-LICES Shampoo is used

Always check the label for directions on howto use it.

Your pharmacist will help if you are not sure.

avoid

eyes;

if you are a healthcare professional in regular contact withthisproductyoushouldwearprotective

gloves;

for external use only;

not for prolonged use;

this product may affect permed, coloured or bleached hair.

Adults, Children and Infants aged 6 months and over:

For head lice– The source of infestation should be sought and treated. Wet hair and apply sufficient

quantity of shampoo to the roots of the hair and scalp and work up a rich lather. Pay special attention to

partings,back of the neck and around the ears. Leave on for at least 10 minutes before rinsing. Comb

the hair whilst wet to remove dead lice and eggs (nits).

A second application is usually recommended a week after the first application.

Bedding,comb,cap,towel, and clothing should be washed to prevent re-infection. Avoid contact with

infected persons.

For pubic lice– Wet the area and apply directly to pubic hair, hair between the legs and around the

anus. Cover the skin and hair completely with the shampoo and work up arichlather.Leaveonforat

least 10 minutes before rinsing. Remove dead lice and eggs (nits) with a fine comb.

A second application is usually recommended a week after the first application.

Bedding,comb, towel, and clothing should be washed to prevent re-infection. Avoid contact with infected

persons.

Side Effects

Very rarely skin irritation.

In Case of Overdose

Immediatelygo to the Accident and Emergencyat yournearesthospitalortelephonetheNew

Zealand National Poisons Information Centre (telephone 0800 POISON or 0800 764 766) if you

think that you or anyone else mayhave swallowed A-LICES Shampoo.

Storage

Do not use any medicine after the expiry date stated on the packaging.

Do not store above 30 °C.

Store in the original package.

Keep it secure where children cannot reach it. Your medicine could harm them.

Ingredients

A-LICESShampoo also contains water, lavender oil, sodium laurylsulfate, sodium chloride, citric acid,

tartrazine, coconut diethanolamide, citrozone, brilliant blue and sodium benzoate.

What to do if you want to know more

Ask your doctor or pharmacist if you have any questions.

Distributor

AFT Pharmaceuticals Limited

P.O. Box 33-203, Takapuna,

AUCKLAND

Date of preparation: 31 July 2007

Document Outline